Role of transforming growth factor β in breast carcinogenesis
- 1 April 2004
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 5 (4) , 229-239
- https://doi.org/10.1016/s1470-2045(04)01426-3
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cellsOncogene, 2002
- Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancerOncogene, 1999
- Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progressionJournal of Mammary Gland Biology and Neoplasia, 1996
- The role of TGF-β in patterning and growth of the mammary ductal treeJournal of Mammary Gland Biology and Neoplasia, 1996
- Transforming Growth Factor βClinical Immunotherapeutics, 1995
- Stifled by inhibitionsNature, 1994
- Mechanism of activation of the TGF-β receptorNature, 1994
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Transforming growth factor beta1 in ductal carcinoma in situ and invasive carcinomas of the breastEuropean Journal Of Cancer, 1992
- Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancerBritish Journal of Cancer, 1991